[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335405-105":59,"doc-detail-335405-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","prognostic-impact-of-invariant-natural-killer-t-cells-in-solid-and-hematological-tumors-systematic-review-and-meta-analysis","Prognostic impact of invariant natural killer T cells in solid and hematological tumors - systematic review and meta-analysis","","Invariant natural killer T (iNKT) cells are an immune subset linking innate and adaptive responses and contributing to anti-cancer immunity through pro-inflammatory cytokines. A systematic review and meta-analysis evaluated the prognostic effect of iNKT cells across solid and hematological malignancies. Searches covered Google Scholar, ScienceDirect, PubMed, Cochrane Central, and Scopus. Intratumoral or circulating iNKT cells showed a positive association with survival (pooled HR 0.89, 95% CI 0.81–0.98; p=0.01), with substantial heterogeneity (I2=87%; p=0.00001).",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-impact-of-invariant-natural-killer-t-cells-in-solid-and-hematological-tumors-systematic-review-and-meta-analysis/335405/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-impact-of-invariant-natural-killer-t-cells-in-solid-and-hematological-tumors-systematic-review-and-meta-analysis/335405.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the objective of the systematic review and meta-analysis?","Question",{"text":112,"@type":113},"To assess the prognostic effect of invariant natural killer T (iNKT) cells across different types of solid and hematological tumors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which databases were used to search for eligible studies?",{"text":117,"@type":113},"Google Scholar, ScienceDirect, PubMed, Cochrane Central, and Scopus were searched systematically to identify relevant articles.",{"name":119,"@type":110,"acceptedAnswer":120},"How did iNKT cells relate to patient survival outcomes?",{"text":121,"@type":113},"Intratumoral or circulating iNKT cells were associated with improved survival, with a pooled hazard ratio of 0.89 (95% CI 0.81–0.98; p=0.01).",{"name":123,"@type":110,"acceptedAnswer":124},"What did the results indicate about heterogeneity among studies?",{"text":125,"@type":113},"There was highly statistical heterogeneity between studied tumors (I2=87%; p=0.00001).","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},335405,1790239731,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":4},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Cancer Biomarkers 41 (2024) 155–164 155  \nDOI 10.3233/CBM-240069 IOS Press  \nPrognostic impact of invariant natural killer T cells in solid and hematological tumors; systematic review and meta-analysis  \nRenad M. Alhamawi􀀃 , Noof Alouﬁ, Abeer F. Alamri, Fatima A. Altubayli, Raghad T. Alsairi,  \nReem A. Alhamad, Shouq M. Alharbi, Zainab A. Ankhli, Hamza M. A. Eid and Yahya A. Almutawif Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taibah University, Medina, Saudi  \nArabia  \nReceived 15 March 2024 Accepted 18 August 2024  \nAbstract.  \nBACKGROUND: Invariant natural killer T (iNKT) cells are an immune subset that purportedly link the adaptive and the innate arms of the immune system. Importantly, iNKT cells contribute to anti-cancer immunity in different types of hematological and solid malignancies by secreting pro-inﬂammatory cytokines. Therefore, using such cells in treating different type of tumors would be an ideal candidate for cancer immunotherapy.  \nOBJECTIVE: To assess the prognostic effect of iNKT cells across different types of solid and hematological tumors. METHODS: In systematic review and meta-analysis, articles assessed the prognostic effect of iNKT cells were systemically searched using the scientiﬁc databases including Google Scholar, ScienceDirect, PubMed, Cochrane Central, and Scopus. RESULTS: Strikingly, the analysis showed the positive impact of intratumoral or circulating iNKT cells on the survival rate inpatients with all studied tumors with overall effect of a pooled hazard ratio of 0.89 (95% CI 0.81 to 0.98; p = 0.01). A highly statistical heterogeneity was noted between studied tumor with I2 = 87%; p = 0.00001.  \nCONCLUSIONS: Taken together, this study would present a new insight into the impact of iNKT cells correlate with caner patients' survival rate and how such cells would be used as a therapeutic target in these patients.  \nKeywords: Cancer, iNKT cells, Immunotherapy, overall survival, disease free survival  \n1. Introduction  \nInvariant natural killer T (iNKT) cell is a unique population of lymphocytes with shared properties of natural killer cells (NK) and T lymphocytes [1] . iNKT cells are distinct from conventional 􀀋􀀌 T cells as they express a semi-invariant T cell recptor that can recognize certain glycolipids when presented by CD1d, non-polymorphic MHC I-like molecule [1,2,3] . Indeed,  \n􀀃 Corresponding author: Renad M. Alhamawi, Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taibah University, P.O. Box 344, Medina 42353, Saudi Arabia. E-mail: [rhamawi@taibahu.edu.sa](rhamawi@taibahu.edu.sa).  \niNKT cells can recognize different glycolipid structures which have distinct immune responses and cytokines production [4] . The most common glycolipid that stimulate iNKT cells is a-galactosyl ceramide (a-GalCer) [5, 6] .  \niNKT cells known to secrete plethora of cytokines that play a crucial role in inﬂammatory diseases and maintain immune homeostasis [3] . iNKT cells have a well-known role in anti-tumor immunity. For example, iNKT cells are remodeling the tumor microenvironment through producing cytokines such as IFN-􀀍 which inhibit angiogenesis [7,8] . Furthermore, iNKT cells eliminate tumor associated macrophages (TAMs) as well as strengthen the responses of CD8 and CD4 T cells that are speciﬁc to tumor associated antigen  \nISSN 1574-0153 􀀍c 2024 – The authors. Published by IOS Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC 4 .0) .  \n156 R.M. Alhamawi et al. / iNKT cells and cancer  \n(TAA) [9, 10, 11] . iNKT cells are also contributed in tumor cells elimination in blood-related cancers through a CD1d-dependent recognition mechanism [12, 13, 14, 15, 16] . For instance, iNKT cells can also promote the maturation of CD1d+ dendritic cells which ultimately activate CD4 and CD8 T cells that contribute to elimination of cancerous cells [17, 18] . Taken","cbCaiibPBBGs0Owe","https://ap.wps.com/l/cbCaiibPBBGs0Owe","pdf",1049875,"English","# Abstract\n## Background\n## Objective\n## Methods\n## Results\n## Conclusions\n# Introduction\n# Materials and methods\n## Search strategy and selection criteria","[{\"question\":\"What was the objective of the systematic review and meta-analysis?\",\"answer\":\"To assess the prognostic effect of invariant natural killer T (iNKT) cells across different types of solid and hematological tumors.\"},{\"question\":\"Which databases were used to search for eligible studies?\",\"answer\":\"Google Scholar, ScienceDirect, PubMed, Cochrane Central, and Scopus were searched systematically to identify relevant articles.\"},{\"question\":\"How did iNKT cells relate to patient survival outcomes?\",\"answer\":\"Intratumoral or circulating iNKT cells were associated with improved survival, with a pooled hazard ratio of 0.89 (95% CI 0.81–0.98; p=0.01).\"},{\"question\":\"What did the results indicate about heterogeneity among studies?\",\"answer\":\"There was highly statistical heterogeneity between studied tumors (I2=87%; p=0.00001).\"}]","Prognostic impact of invariant natural killer T cells in solid and hematological tumors - systematic review and meta-analysis | PDF",1790010840,25]